1. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., Holmberg, S. D.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338 (1998) 853–860.
2. Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J. P., O'Shaughnessy, M. V., Schechter, M. T., Montaner, J. S. G.: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 279 (1998) 459–454.
3. Lavie, A., Schlichting, I., Vetter, I. R., Konrad M., Reinstein, J., Goody, R. S.: The botleneck in AZT activation. Nature 3 (1997) 922–924.
4. Jacobsson, B., Britton, S., He, Q., Karlsson, A., Eriksson, S.: Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. AIDS Res. Hum. Retroviruses 11 (1995) 805–811.
5. Sommadossi, J.-P., Zhou, X., Moore, J., Havlir, D. V., Fridland, G., Tierney, C., Smeaton, L., Fox, L., Richman, D., Polland, R. and the ACTG 290 Team: Impairment of stavudine phosphorylation in patients receiving a combination of zidovudine and stavudine. Abstr.; 5th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, February 1998.